About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials in Tennessee | 898 Studies

Clinical Trials Lung CancerTennessee

Lung Cancer Clinical Trials in Tennessee

Find 898 clinical trials for lung cancer near Tennessee. Connect with research centers in your area.

All Lung Cancer trials nationwide All trials in Tennessee

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 481-500 of 898 trials

TerminatedQUILT-2.017: Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment of Advanced Squamous Non-Small Cell Lung CancerThis is a global, multicenter, 2-part, open-label phase 1b and single-arm phase 2 study designed to evaluate the safety and efficacy of AMG 479 in combination with paclitaxel and…NCT00807612·Fayetteville, Arkansas and 24 others RecruitingA Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.This is a study to evaluate the safety and efficacy of EIK1001 administered intravenously in combination with pembrolizumab and histologically appropriate chemotherapy for…NCT07365319·Daphne, Alabama and 41 others

Lung Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingA Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid TumorsThe study treatment, BAY 3713372, is under development to treat MTAP (methylthioadenosine phosphorylase)-deleted solid tumors.NCT06914128·Birmingham, Alabama and 62 others

CompletedBioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesThis is a Phase 1, open-label, multicenter, randomized, 2-stage crossover study consisting of 2 phases: Stage I - Pharmacokinetics (Bioequivalence), with an Extension Stage II -…NCT02223052·Scottsdale, Arizona and 9 others

CompletedA Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of CancersIn this study, adults with non-small-cell lung cancer (NSCLC), triple-negative breast cancer (TNBC) and squamous-cell carcinoma of the head and neck (SCCHN) will be treated with…NCT04879849·Duarte, California and 4 others

RecruitingTesting the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer…NCT04267848·Anchorage, Alaska and 1150 others

CompletedA Study of Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC)This non-randomized, open-label, multicenter study will evaluate the safety and efficacy of alectinib in participants with ALK-rearranged non-small cell lung cancer who failed…NCT01871805·Birmingham, Alabama and 41 others

CompletedS9925: Collecting and Storing Samples From Patients With Lung CancerRATIONALE: Collecting and storing samples of tissue, blood, and sputum from patients with cancer to study in the laboratory may help the study of cancer in the future.NCT00920010·Mobile, Alabama and 430 others

UnknownRBN-2397 in Combination With Pembrolizumab in Patients With SCCLRBN-2397 inhibits PARP7, an enzyme that is switched on by cancer stresses, such as the toxins in cigarette smoke.NCT05127590·Newark, Delaware and 18 others

CompletedErlotinib in Treating Patients With Advanced Non-Small Cell Lung CancerRATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00416650·Chicago, Illinois and 3 others

CompletedA Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent MalignanciesThe purpose of this study is to determine the safety and effectiveness of MDX-1106 in patients with certain types of cancer.NCT00730639·Scottsdale, Arizona and 12 others

RecruitingA Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung CancerLung cancer is one of the most common forms of cancer. One common type is non-small cell lung cancer (NSCLC).NCT07217301·Jonesboro, Arkansas and 49 others

Active not recruitingONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 InhibitorsThe goal of this Phase 3 clinical trial is to study the safety and efficacy of the nextgen anti-CTLA-4 antibody, gotistobart (ONC-392/BNT316), in patients with metastatic…NCT05671510·Dothan, Alabama and 151 others

CompletedA Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.The purposes of this study are to determine the following: Whether LY900003 plus gemcitabine and carboplatin can make your tumor smaller or disappear, and for how long.NCT00042679·Bakersfield, California and 10 others

CompletedGene Therapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung CancerRATIONALE: Inserting the gene for p53 into a person's cancer cells may improve the body's ability to fight cancer. Radiation therapy uses high-energy x-rays to damage tumor cells.NCT00004225·Nashville, Tennessee

CompletedA Study of TAK-788 in Adults With Non-Small Cell Lung CancerThis study is about a medicine called TAK-788, also known as mobocertinib, given to adults with non-small cell lung cancer.NCT02716116·Birmingham, Alabama and 61 others

TerminatedPolyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00054184·Hoover, Alabama and 34 others

CompletedStudy of DF1001 in Patients With Advanced Solid TumorsDF1001-001 is a study of a new molecule that targets natural killer (NK) cells and T-cell activation signals to specific receptors on cancer cells.NCT04143711·Irvine, California and 43 others

CompletedA Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Advanced NSCLC* To evaluate the safety and tolerability of escalating doses of ERAS-007 or ERAS-601 in combination with other cancer therapies in study participants with advanced non-small cell…NCT04959981·Duarte, California and 10 others

WithdrawnCombination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerRATIONALE: Drugs used in chemotherapy such as gemcitabine, carboplatin, and paclitaxel use different ways to stop tumor cells from dividing so they stop growing or die.NCT00054392·Loma Linda, California and 56 others

PreviousPage 25 of 45Next

Other Conditions in Tennessee

Breast Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma